Roche Holding AG (OTCMKTS:RHHBY) Receives Average Rating of "Hold" from Brokerages

Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) has been assigned a consensus rating of "Hold" from the six ratings firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, one has issued a buy rating and one has issued a strong buy rating on the company.

RHHBY has been the subject of a number of analyst reports. Sanford C. Bernstein raised Roche to a "strong-buy" rating in a research note on Thursday, January 30th. Morgan Stanley began coverage on Roche in a research report on Wednesday, February 12th. They issued an "equal weight" rating for the company.

Roche Stock Performance

Shares of Roche stock traded down $0.24 on Wednesday, reaching $41.05. 1,158,538 shares of the stock were exchanged, compared to its average volume of 1,758,382. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86. Roche has a 1-year low of $29.20 and a 1-year high of $42.43. The business has a fifty day moving average price of $37.14 and a two-hundred day moving average price of $38.31.

Institutional Investors Weigh In On Roche

Several institutional investors have recently modified their holdings of the company. HighPoint Advisor Group LLC raised its holdings in Roche by 2.8% during the fourth quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock worth $387,000 after purchasing an additional 304 shares during the last quarter. Hantz Financial Services Inc. raised its stake in shares of Roche by 0.9% during the 4th quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company's stock worth $1,176,000 after buying an additional 305 shares during the last quarter. Canopy Partners LLC grew its stake in Roche by 4.6% in the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company's stock valued at $310,000 after acquiring an additional 344 shares during the last quarter. Brooklyn Investment Group grew its stake in Roche by 36.6% in the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company's stock valued at $48,000 after acquiring an additional 363 shares during the last quarter. Finally, Altrius Capital Management Inc increased its holdings in Roche by 0.3% during the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company's stock valued at $6,399,000 after acquiring an additional 603 shares in the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.